Biblio
“Nucleotide sequence of cDNA encoding bonnet monkey (Macaca radiata) zona pellucida glycoprotein-ZP3”, Reproduction, Fertility and Development, vol. 7, pp. 1209–1212, 1995.
, “Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor”, Experimental cell research, vol. 226, pp. 154–163, 1996.
, “Mapping of epitopes on porcine zona pellucida-3 alpha by monoclonal antibodies inhibiting oocyte-sperm interaction.”, Biology of reproduction, vol. 55, pp. 410–415, 1996.
, “p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells”, Genes & Development, vol. 13, no. 13, pp. 1742 - 1753, 1999.
, “Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3”, Science, vol. 289, pp. 1159–1164, 2000.
“Orphan receptor COUP-TF is required for induction of retinoic acid receptor $\beta$, growth inhibition, and apoptosis by retinoic acid in cancer cells”, Molecular and cellular biology, vol. 20, pp. 957–970, 2000.
, “Unique anti-activator protein-1 activity of retinoic acid receptor $\beta$”, Cancer research, vol. 60, pp. 3271–3280, 2000.
, “Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity”, Cancer research, vol. 61, pp. 4723–4730, 2001.
“Novel Target Genes of the Ah (Dioxin) Receptor Transcriptional Induction of N-Myristoyltransferase 2”, Cancer research, vol. 61, pp. 8534–8539, 2001.
, “Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor”, Journal of Biological Chemistry, vol. 277, pp. 21414–21422, 2002.
, “Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells”, Molecular and cellular biology, vol. 23, pp. 8651–8667, 2003.
, “Regulation of retinoic acid receptor $\beta$ expression by peroxisome proliferator-activated receptor $\gamma$ ligands in cancer cells”, Cancer Research, vol. 63, pp. 3531–3538, 2003.
, “Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3”, Cell, vol. 116, pp. 527–540, 2004.
, “Determinants of Retinoid X Receptor Transcriptional Antagonism”, Journal of Medicinal Chemistry, vol. 47, no. 18, pp. 4360 - 4372, 2004.
, “TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway.”, Oncogene, vol. 24, no. 31, pp. 4975-83, 2005.
, “Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt”, Oncogene, vol. 25, pp. 2974–2986, 2006.
, “Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma”, Blood, vol. 109, no. 9, pp. 3849 - 3855, 2007.
, “A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer”, Cancer Cell, vol. 14, no. 4, pp. 285 - 298, 2008.
, “Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands”, Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5635 - 5641, 2009.
, “The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor”, PLoS ONE, vol. 5, no. 10, p. e13128, 2010.
, “Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro”, Toxicological sciences, p. kfq379, 2010.
, “Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism”, Journal of Pharmacology and Experimental Therapeutics, vol. 338, pp. 318–327, 2011.
, “Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3′, 4′-dimethoxy-$\alpha$-naphthoflavone”, Molecular pharmacology, vol. 79, pp. 508–519, 2011.
, “Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model”, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 156, no. 2, pp. 121 - 129, 2012.
, “The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells”, PLoS ONE, vol. 7, no. 7, p. e40926, 2012.
,